Evidence map›Paper›PMID 37742292›Full record

ArticleBiomolecular NMR assignments2023

Ilona Pitkänen, Helena Tossavainen, Perttu Permi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecular NMR assignments, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ilona PitkänenDepartment of Biological and Environmental Science, University of Jyvaskyla, FI-40014, Jyvaskyla, Finland.ORCID 0000-0003-4693-0708
Helena TossavainenDepartment of Biological and Environmental Science, University of Jyvaskyla, FI-40014, Jyvaskyla, Finland.ORCID 0000-0002-1609-1651
Perttu PermiDepartment of Biological and Environmental Science, University of Jyvaskyla, FI-40014, Jyvaskyla, Finland. perttu.permi@jyu.fi.ORCID 0000-0002-6281-1138
University of Jyväskylä · FIHelsinki Institute of Physics · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is a growing problem and a global threat for modern healthcare. New approaches complementing the traditional antibiotic drugs are urgently needed to secure the ability to treat bacterial infections also in the future. Among the promising alternatives are bacteriolytic enzymes, such as the cell wall degrading peptidoglycan hydrolases. Staphylococcus aureus LytM, a Zn

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcus aureusAnti-Bacterial AgentsNuclear Magnetic Resonance, BiomolecularPeptidoglycanAnti-Bacterial AgentsPeptidoglycanHa-detectionLytMNMR spectroscopyS. aureus

Identifiers

PMID37742292
PMCPMC10630248
OpenAlexW4386998904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.